Literature DB >> 15517462

The enteric toxins of Clostridium perfringens.

J G Smedley1, D J Fisher, S Sayeed, G Chakrabarti, B A McClane.   

Abstract

The Gram-positive pathogen Clostridium perfringens is a major cause of human and veterinary enteric disease largely because this bacterium can produce several toxins when present inside the gastrointestinal tract. The enteric toxins of C. perfringens share two common features: (1) they are all single polypeptides of modest (approximately 25-35 kDa) size, although lacking in sequence homology, and (2) they generally act by forming pores or channels in plasma membranes of host cells. These enteric toxins include C. perfringens enterotoxin (CPE), which is responsible for the symptoms of a common human food poisoning and acts by forming pores after interacting with intestinal tight junction proteins. Two other C. perfringens enteric toxins, epsilon-toxin (a bioterrorism select agent) and beta-toxin, cause veterinary enterotoxemias when absorbed from the intestines; beta- and epsilon-toxins then apparently act by forming oligomeric pores in intestinal or extra-intestinal target tissues. The action of a newly discovered C. perfringens enteric toxin, beta2 toxin, has not yet been defined but precedent suggests it might also be a pore-former. Experience with other clostridial toxins certainly warrants continued research on these C. perfringens enteric toxins to develop their potential as therapeutic agents and tools for cellular biology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517462     DOI: 10.1007/s10254-004-0036-2

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  62 in total

1.  Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells.

Authors:  Gregor Guttenberg; Sven Hornei; Thomas Jank; Carsten Schwan; Wei Lü; Oliver Einsle; Panagiotis Papatheodorou; Klaus Aktories
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Virulence plasmid diversity in Clostridium perfringens type D isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

4.  Cloning of alpha-beta fusion gene from Clostridium perfringens and its expression.

Authors:  Jia-Ning Bai; Yan Zhang; Bao-Hua Zhao
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative.

Authors:  Meredith L Hughes; Rachael Poon; Vicki Adams; Sameera Sayeed; Juliann Saputo; Francisco A Uzal; Bruce A McClane; Julian I Rood
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

6.  Structural and functional analysis of four family 84 glycoside hydrolases from the opportunistic pathogen Clostridium perfringens.

Authors:  Benjamin Pluvinage; Patricia M Massel; Kristyn Burak; Alisdair B Boraston
Journal:  Glycobiology       Date:  2019-12-12       Impact factor: 4.313

Review 7.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

Review 8.  Cyclodextrin derivatives as anti-infectives.

Authors:  Vladimir A Karginov
Journal:  Curr Opin Pharmacol       Date:  2013-09-04       Impact factor: 5.547

Review 9.  The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.

Authors:  Mehmet Kanbay; Emine M Onal; Baris Afsar; Tuncay Dagel; Aslihan Yerlikaya; Adrian Covic; Nosratola D Vaziri
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

10.  Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum.

Authors:  Kristin M Marshall; Marite Bradshaw; Eric A Johnson
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.